Navigation Links
Using fluctuating wind power
Date:3/25/2013

Incorporating wind power into existing power grids is challenging because fluctuating wind speed and direction means turbines generate power inconsistently. Coupled with customers' varying power demand, many wind-farm managers end up wasting power-generation capacity and limiting the service life of turbines through active control including fully stopping turbines in order to avoid any possible damage to the power grid from spikes in supply. In a paper published in the American Institute of Physics' Journal of Renewable and Sustainable Energy, researchers propose a new strategy to optimize power-generation efficiency and so better control wind farms.

The new strategy is based on continuous predictions of how fluctuating winds affect each turbine's maximum generation capacity. It also incorporates factors missing in other wind-farm control strategies, including differing power generation between turbines, actual fluctuations in power generation capacity, errors in prediction, communication disruptions preventing active control, and even turbines without the capacity for continuous active control. To demonstrate the feasibility of the new strategy, the researchers compared their predictions to raw data from a single wind turbine. The team then further refined their calculations and simulated a control operation with data from a wind farm of 33 turbines.

The results suggest that wind-farm managers can improve their power-generation efficiency with the new strategy. However, the researchers caution that before implementing the strategy, each wind-farm manager should adjust the underlying parameters such as how often to adjust each turbine's speed based on local conditions.


'/>"/>
Contact: Catherine Meyers
cmeyers@aip.org
301-209-3088
American Institute of Physics
Source:Eurekalert

Page: 1

Related biology news :

1. Studies reveal structure of EV71, a virus causing childhood illnesses
2. BYU study: Using a gun in bear encounters doesnt make you safer
3. The shape of things to come: NIST probes the promise of nanomanufacturing using DNA origami
4. Beyond the microscope: Identifying specific cancers using molecular analysis
5. Cell therapy using patients own bone marrow may present option for heart disease
6. Using cell phones to detect harmful airborne substances
7. Disarming disease-causing bacteria
8. Notre Dame researchers using novel method to combat malaria drug resistance
9. High-resolution atomic imaging of specimens in liquid by TEM using graphene liquid cell
10. What is really causing the child obesity epidemic?
11. Better housing conditions for zebrafish could improve research results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... VIEW, Calif. , July 7, 2015 /PRNewswire/ ... biometrics market, Frost & Sullivan recognizes Credence ID, ... Sullivan Entrepreneurial Company of the Year Award. ... suite to aid in its mission of offering ... under-recognized populations globally. As Credence ID was formed ...
(Date:7/2/2015)... , June 25, 2015 ... addition of the "Next Generation Biometrics Market by ... 2020" report to their offering. The ... Billion by 2020, at a CAGR of 17.9% between ... the leading application for the market. Safran SA ...
(Date:6/30/2015)... Genisphere announced Tom Bliss ... further develop Genisphere,s therapeutics capabilities and portfolio. Mr. Bliss ... much of the last 25 years in leadership positions ... Johnson & Johnson. Tom started his career in Investment ... Finance. He graduated from Dartmouth College with a BA ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... Northwestern University Feinberg School of Medicine in Chicago, a ... led by Kezhong Zhang, Ph.D., has contributed to an ... inhibitor for the treatment of rheumatoid arthritis. The ... microbiology and Wayne State,s Center for Molecular Medicine and ...
... immune system is a double-edged sword. While its primary ... overactive, leading to problems like allergies and autoimmune diseases. ... responsible for resisting parasites acts by releasing white blood ... eosinophil levels are also responsible for allergic reactions, including ...
... Nov. 12, 2013  Decision Resources, one of the world,s ... issues, finds that while most of the biomarker-drug success ... in pharmaceutical development of chronic conditions, and their use ... building. The Strategic Insights report entitled Driving ...
Cached Biology News:Wayne State researchers discover specific inhibitor for rheumatoid arthritis treatment 2Putting the brakes on immunity 2Putting the brakes on immunity 3Use of Biomarkers in Clinical Trials for Drugs Outside of Oncology is Increasing 2
(Date:7/30/2015)... July 30, 2015 HIGHLIGHTS:Q2 2015 ... 2014) , Reported sales were $697 million compared ... Sales grew organically by 8%, and changes in foreign ... increased sales by 1%. , By business unit, ... Applied and 11% in SAFC Commercial. , Reported ...
(Date:7/29/2015)... July 30, 2015 Sanofi, ... for the second quarter of 2015. CEO ... and its performance in different businesses. ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in ... - Performance drivers - ...
(Date:7/29/2015)... Japan (Q2 2015: +14% CER / 20% of sales) led the ... China , as well as solid contributions from Korea, ... / Middle East / Africa ... Germany , Turkey and the ... sales) grew 11%, excluding U.S. HPV sales, on demand across all customer classes. ...
(Date:7/29/2015)... ... July 29, 2015 , ... G-CON ... the launch of their 2nd generation cell therapy POD® design. The 2nd generation ... it also represents a new POD® design. , “G-CON first offered our ...
Breaking Biology Technology:Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3
... Inc. said it has raised $1.4 million in a ... now about a year old, is developing University of Wisconsin-Madison ... Instead of trying to store the hydrogen, Virent's method involves ... the engine heat to drive a chemical reaction. , ,The ...
... the Legislature are bogged down in a budget fight, just ... it is in Wisconsin. But there's an important distinction between ... of the few areas of agreement, not a source of ... lawmakers and Governor Tim Pawlenty are behind schedule in most ...
... to reach double-digit growth in 2004 for the first time ... concerns over drug safety, pricing and competition from generic drugs ... a look at how the market did. This is according ... firm: , ,If the overall growth of the ...
Cached Biology Technology:Feuds between UW and the Legislature should end for good of the state 2Feuds between UW and the Legislature should end for good of the state 3Though pharma growth slides, blockbusters reach new record 2Though pharma growth slides, blockbusters reach new record 3
... modular benchtop fume hood ventilates ... safe indoor release of exhaust. ... organic contaminants. Configurations are available ... options include final HEPA filter, ...
...
... systems provide fast and reliable scalable automation ... and drug development laboratories. Staccato systems are ... Series, Application Series and Custom Systems Series. ... remarkably compact system for performing ELISA assays. ...
... filter/fan unit provides continuous vertical flow of ... (ISO 5) cleanliness standards , ... and disinfect , Large, ergonomically ... allow insertion of filling machines or other ...
Biology Products: